Review article: Coagulation and fibrinolysis in diabetes

Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease

(2013) William L. Baker   ANNALS OF INTERNAL MEDICINE

An Update on the Role of Markers of Inflammation in Atherosclerosis

(2011) Egle Corrado et al.   Journal of Atherosclerosis and Thrombosis

Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia

(2010) Peggy Kostakou et al.   Archives of Cardiovascular Diseases

Higher Fibrinogen Levels Predict Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes

(2010) T.C. Rodrigues et al.   ATHEROSCLEROSIS

Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options

(2010) R. De Caterina et al.   EUROPEAN HEART JOURNAL

Rosiglitazone Reduces Plasma Levels of Inflammatory and Hemostatic Biomarkers and Improves Global Endothelial Function in Habitual Heavy Smokers Without Diabetes Mellitus or Metabolic Syndrome

(2010) I-Chih Chen et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Fibrinogen is associated with silent myocardial ischaemia in type 2 diabetes mellitus

(2009) R. Guardado- Mendoza et al.   ACTA CARDIOLOGICA

Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System

(2009) R.A. Ajjan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Atherogenesis and atherothrombosis – focus on diabetes mellitus

(2009) Bernd Stratmann et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion

(2009) M.E. Andrades et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Tissue Factor and Cardiovascular Disease:

(2009) Alexander Breitenstein et al.   CIRCULATION JOURNAL

Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2)

(2009) R.A. Karatela et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules

(2009) Hongbin Liu et al.   JOURNAL OF ENDOCRINOLOGY

Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study

(2009) D. GREEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes

(2009) A. CERIELLO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo

(2009) Koji Yamamoto et al.   THROMBOSIS RESEARCH

Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury

(2008) L. Wang et al.   BLOOD

Cardiovascular disease and heritability of the prothrombotic state

(2008) R.A. Ajjan et al.   BLOOD REVIEWS

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome

(2008) A. Undas et al.   DIABETES CARE

The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes

(2008) Duc Son N.T. Le et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans

(2008) M. E. Stegenga et al.   DIABETIC MEDICINE

Aspirin resistance and diabetes mellitus

(2008) R. Ajjan et al.   DIABETOLOGIA

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Association between serious ischemic cardiac outcomes and medications used to treat diabetes

(2008) David J. Margolis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes

(2008) David Sahli et al.   THROMBOSIS RESEARCH

Thrombin generation, fibrin clot formation and hemostasis

(2008) Alisa S. Wolberg et al.   TRANSFUSION AND APHERESIS SCIENCE

Common variation in the C-terminal region of the fibrinogen -chain: effects on fibrin structure, fibrinolysis and clot rigidity

(2007) R. Ajjan et al.   BLOOD